Study how radiation and cisplatin affect hearing in head and neck cancer
Part of Brain & nervous system, Cancer, Ear, nose & throat clinical trials.
This study looks at how radiotherapy, and possibly cisplatin chemotherapy, affect hearing in people treated for head and neck cancer. It may help doctors better predict hearing side effects and plan hearing monitoring or prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have been diagnosed with head and neck cancer
- For treatment-based groups: your care team must plan radiotherapy, with or without cisplatin chemotherapy
- You should not start the study with significant hearing loss (details vary by group, based on hearing test results)
- You must not be planned for carboplatin-based chemotherapy
- Be able to understand the study and give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how cisplatin chemotherapy affects hearing and balance in people with head and neck cancer. It compares patients who get cisplatin with those who only get radiation, to understand and possibly reduce these side effects.
This Phase 2 trial tests whether a cholesterol medicine called atorvastatin can protect hearing in people with head and neck cancer receiving cisplatin plus radiation. If it works, it may reduce the chance or severity of treatment-related hearing damage.
This trial tests whether adding Pedmark (sodium thiosulfate) to cisplatin chemotherapy can protect hearing in men with stage II or III testicular germ cell tumors. It aims to reduce the risk of drug-related ear damage while still treating the cancer.
This study looks at whether certain cancer drugs affect hearing, and whether some patients have less access to hearing care. You'll take online hearing and memory tests to help researchers understand this problem better.
This study tests a remote hearing test to monitor hearing changes in patients with head and neck cancer getting cisplatin chemotherapy and/or radiation. The goal is to catch hearing loss early so treatment can be adjusted.
This study looks at how tinnitus (ringing in the ears) and hearing problems may develop after radiotherapy alone or with certain chemotherapy for high-risk head and neck cancer. The goal is to better understand who is more likely to experience these side effects.
Hear when a new Head and Neck Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.